Ameritas Investment Partners’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
AIM
NAMA
VCM
VPM
Ameritas Investment Partners's ARCT Position: Q1 2026 in Review
Ameritas Investment Partners held its Arcturus Therapeutics (ARCT) position steady in Q1 2026 at 2,317 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2640.
Ameritas Investment Partners first reported a position in ARCT in Q2 2020 and has held it in 24 quarters since. The position peaked at $80K in Q4 2020. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.
- Ameritas Investment Partners held 2,317 shares of Arcturus Therapeutics worth $17.9K as of Q1 2026.
- Ameritas Investment Partners left its Arcturus Therapeutics share count unchanged in Q1 2026.
- Arcturus Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2640 holding.
- Ameritas Investment Partners first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 24 quarters since.
- Ameritas Investment Partners's Arcturus Therapeutics position peaked at $80K in Q4 2020.
- 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.